HEADER VIRAL PROTEIN 29-JUL-19 6KL5 TITLE STRUCTURE OF THE N-TERMINAL DOMAIN OF MIDDLE EAST RESPIRATORY SYNDROME TITLE 2 CORONAVIRUS NUCLEOCAPSID PROTEIN COMPLEXED WITH BENZYL 2- TITLE 3 (HYDROXYMETHYL)-1-INDOLINECARBOXYLATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEOPROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MIDDLE EAST RESPIRATORY SYNDROME-RELATED SOURCE 3 CORONAVIRUS; SOURCE 4 ORGANISM_TAXID: 1335626; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NUCLEOCAPSID PROTEIN; KEYWDS 2 N-TERMINAL DOMAIN; BENZYL 2-(HYDROXYMETHYL)-1-INDOLINE CARBOXYLATE, KEYWDS 3 VIRUS, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.H.HOU,S.M.LIN,J.N.HSU,Y.S.WANG REVDAT 3 22-NOV-23 6KL5 1 REMARK REVDAT 2 08-APR-20 6KL5 1 JRNL REVDAT 1 25-MAR-20 6KL5 0 JRNL AUTH S.M.LIN,S.C.LIN,J.N.HSU,C.K.CHANG,C.M.CHIEN,Y.S.WANG,H.Y.WU, JRNL AUTH 2 U.S.JENG,K.KEHN-HALL,M.H.HOU JRNL TITL STRUCTURE-BASED STABILIZATION OF NON-NATIVE PROTEIN-PROTEIN JRNL TITL 2 INTERACTIONS OF CORONAVIRUS NUCLEOCAPSID PROTEINS IN JRNL TITL 3 ANTIVIRAL DRUG DESIGN. JRNL REF J.MED.CHEM. V. 63 3131 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32105468 JRNL DOI 10.1021/ACS.JMEDCHEM.9B01913 REMARK 2 REMARK 2 RESOLUTION. 3.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.09 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.29 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.450 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.8 REMARK 3 NUMBER OF REFLECTIONS : 11927 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.283 REMARK 3 R VALUE (WORKING SET) : 0.281 REMARK 3 FREE R VALUE : 0.299 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.930 REMARK 3 FREE R VALUE TEST SET COUNT : 1184 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 6.1285 - 6.1285 0.99 1464 156 0.2594 0.3087 REMARK 3 2 6.1285 - 4.8745 0.97 1412 156 0.2594 0.2749 REMARK 3 3 4.8745 - 4.2613 0.94 1369 148 0.2594 0.2594 REMARK 3 4 4.2613 - 3.8730 0.94 1336 152 0.2594 0.3158 REMARK 3 5 3.8730 - 3.5961 0.96 1368 157 0.2594 0.2989 REMARK 3 6 3.5961 - 3.3846 0.94 1366 148 0.2594 0.2970 REMARK 3 7 3.3846 - 3.2154 0.91 1288 140 0.2594 0.3224 REMARK 3 8 3.2154 - 3.0900 0.78 1140 127 0.2594 0.3943 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.480 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.290 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6KL5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-AUG-19. REMARK 100 THE DEPOSITION ID IS D_1300001470. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-SEP-15 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : BL13C1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97622 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12334 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.076 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.13700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.09 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.48100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4J3K REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5 MG/ML PROTEIN, 25 MM TRIS-HCL, PH REMARK 280 7.5, 75 MM NACL, 70 MM MES, PH5.5, 37.5 M (NH4)2SO4, 14.5 % PEG REMARK 280 3350, 1 MM NABR, 1MM, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 54.94850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 22 REMARK 465 HIS A 23 REMARK 465 HIS A 24 REMARK 465 HIS A 25 REMARK 465 HIS A 26 REMARK 465 HIS A 27 REMARK 465 SER A 28 REMARK 465 SER A 29 REMARK 465 GLY A 30 REMARK 465 LEU A 31 REMARK 465 VAL A 32 REMARK 465 PRO A 33 REMARK 465 ARG A 34 REMARK 465 GLY A 35 REMARK 465 SER A 36 REMARK 465 HIS A 37 REMARK 465 MET A 38 REMARK 465 ASN A 39 REMARK 465 THR A 40 REMARK 465 LYS A 84 REMARK 465 ILE A 85 REMARK 465 ASN A 86 REMARK 465 THR A 87 REMARK 465 GLY A 88 REMARK 465 ASN A 89 REMARK 465 GLY A 90 REMARK 465 ILE A 91 REMARK 465 LYS A 92 REMARK 465 GLY A 164 REMARK 465 THR A 165 REMARK 465 HIS B 22 REMARK 465 HIS B 23 REMARK 465 HIS B 24 REMARK 465 HIS B 25 REMARK 465 HIS B 26 REMARK 465 HIS B 27 REMARK 465 SER B 28 REMARK 465 SER B 29 REMARK 465 GLY B 30 REMARK 465 LEU B 31 REMARK 465 VAL B 32 REMARK 465 PRO B 33 REMARK 465 ARG B 34 REMARK 465 GLY B 35 REMARK 465 ASN B 86 REMARK 465 THR B 87 REMARK 465 GLY B 88 REMARK 465 ASN B 89 REMARK 465 GLY B 90 REMARK 465 ILE B 91 REMARK 465 THR B 165 REMARK 465 HIS C 22 REMARK 465 HIS C 23 REMARK 465 HIS C 24 REMARK 465 HIS C 25 REMARK 465 HIS C 26 REMARK 465 HIS C 27 REMARK 465 SER C 28 REMARK 465 SER C 29 REMARK 465 GLY C 30 REMARK 465 LEU C 31 REMARK 465 VAL C 32 REMARK 465 PRO C 33 REMARK 465 ARG C 34 REMARK 465 GLY C 35 REMARK 465 SER C 36 REMARK 465 HIS C 37 REMARK 465 MET C 38 REMARK 465 ASN C 39 REMARK 465 ASP C 82 REMARK 465 ARG C 83 REMARK 465 LYS C 84 REMARK 465 ILE C 85 REMARK 465 ASN C 86 REMARK 465 THR C 87 REMARK 465 GLY C 88 REMARK 465 ASN C 89 REMARK 465 GLY C 90 REMARK 465 ILE C 91 REMARK 465 LYS C 92 REMARK 465 GLN C 93 REMARK 465 LEU C 94 REMARK 465 ALA C 95 REMARK 465 PRO C 96 REMARK 465 LYS C 158 REMARK 465 ASN C 159 REMARK 465 PHE C 160 REMARK 465 HIS C 161 REMARK 465 ILE C 162 REMARK 465 GLU C 163 REMARK 465 GLY C 164 REMARK 465 THR C 165 REMARK 465 HIS D 22 REMARK 465 HIS D 23 REMARK 465 HIS D 24 REMARK 465 HIS D 25 REMARK 465 HIS D 26 REMARK 465 HIS D 27 REMARK 465 SER D 28 REMARK 465 SER D 29 REMARK 465 GLY D 30 REMARK 465 LEU D 31 REMARK 465 VAL D 32 REMARK 465 PRO D 33 REMARK 465 ARG D 34 REMARK 465 GLY D 35 REMARK 465 SER D 36 REMARK 465 HIS D 37 REMARK 465 MET D 38 REMARK 465 ASN D 39 REMARK 465 ASP D 82 REMARK 465 ARG D 83 REMARK 465 LYS D 84 REMARK 465 ILE D 85 REMARK 465 ASN D 86 REMARK 465 THR D 87 REMARK 465 GLY D 88 REMARK 465 ASN D 89 REMARK 465 GLY D 90 REMARK 465 ILE D 91 REMARK 465 LYS D 92 REMARK 465 GLN D 93 REMARK 465 LEU D 94 REMARK 465 ALA D 95 REMARK 465 ASN D 159 REMARK 465 PHE D 160 REMARK 465 HIS D 161 REMARK 465 ILE D 162 REMARK 465 GLU D 163 REMARK 465 GLY D 164 REMARK 465 THR D 165 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CG1 VAL C 41 O ARG C 138 1.84 REMARK 500 OG SER D 42 O PHE D 100 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 107 C - N - CA ANGL. DEV. = 12.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 114 17.28 59.13 REMARK 500 HIS B 37 -52.54 67.96 REMARK 500 THR B 40 -15.58 -142.98 REMARK 500 PRO B 64 152.20 -49.26 REMARK 500 PRO B 140 0.51 -60.60 REMARK 500 PRO C 140 -8.39 -59.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DJO A 201 DBREF1 6KL5 A 39 165 UNP A0A0D3MU65_9BETC DBREF2 6KL5 A A0A0D3MU65 39 165 DBREF1 6KL5 B 39 165 UNP A0A0D3MU65_9BETC DBREF2 6KL5 B A0A0D3MU65 39 165 DBREF1 6KL5 C 39 165 UNP A0A0D3MU65_9BETC DBREF2 6KL5 C A0A0D3MU65 39 165 DBREF1 6KL5 D 39 165 UNP A0A0D3MU65_9BETC DBREF2 6KL5 D A0A0D3MU65 39 165 SEQADV 6KL5 HIS A 22 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS A 23 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS A 24 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS A 25 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS A 26 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS A 27 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 SER A 28 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 SER A 29 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 GLY A 30 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 LEU A 31 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 VAL A 32 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 PRO A 33 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 ARG A 34 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 GLY A 35 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 SER A 36 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS A 37 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 MET A 38 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS B 22 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS B 23 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS B 24 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS B 25 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS B 26 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS B 27 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 SER B 28 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 SER B 29 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 GLY B 30 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 LEU B 31 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 VAL B 32 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 PRO B 33 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 ARG B 34 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 GLY B 35 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 SER B 36 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS B 37 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 MET B 38 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS C 22 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS C 23 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS C 24 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS C 25 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS C 26 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS C 27 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 SER C 28 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 SER C 29 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 GLY C 30 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 LEU C 31 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 VAL C 32 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 PRO C 33 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 ARG C 34 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 GLY C 35 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 SER C 36 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS C 37 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 MET C 38 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS D 22 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS D 23 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS D 24 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS D 25 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS D 26 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS D 27 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 SER D 28 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 SER D 29 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 GLY D 30 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 LEU D 31 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 VAL D 32 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 PRO D 33 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 ARG D 34 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 GLY D 35 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 SER D 36 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 HIS D 37 UNP A0A0D3MU6 EXPRESSION TAG SEQADV 6KL5 MET D 38 UNP A0A0D3MU6 EXPRESSION TAG SEQRES 1 A 144 HIS HIS HIS HIS HIS HIS SER SER GLY LEU VAL PRO ARG SEQRES 2 A 144 GLY SER HIS MET ASN THR VAL SER TRP TYR THR GLY LEU SEQRES 3 A 144 THR GLN HIS GLY LYS VAL PRO LEU THR PHE PRO PRO GLY SEQRES 4 A 144 GLN GLY VAL PRO LEU ASN ALA ASN SER THR PRO ALA GLN SEQRES 5 A 144 ASN ALA GLY TYR TRP ARG ARG GLN ASP ARG LYS ILE ASN SEQRES 6 A 144 THR GLY ASN GLY ILE LYS GLN LEU ALA PRO ARG TRP TYR SEQRES 7 A 144 PHE TYR TYR THR GLY THR GLY PRO GLU ALA ALA LEU PRO SEQRES 8 A 144 PHE ARG ALA VAL LYS ASP GLY ILE VAL TRP VAL HIS GLU SEQRES 9 A 144 ASP GLY ALA THR ASP ALA PRO SER THR PHE GLY THR ARG SEQRES 10 A 144 ASN PRO ASN ASN ASP SER ALA ILE VAL THR GLN PHE ALA SEQRES 11 A 144 PRO GLY THR LYS LEU PRO LYS ASN PHE HIS ILE GLU GLY SEQRES 12 A 144 THR SEQRES 1 B 144 HIS HIS HIS HIS HIS HIS SER SER GLY LEU VAL PRO ARG SEQRES 2 B 144 GLY SER HIS MET ASN THR VAL SER TRP TYR THR GLY LEU SEQRES 3 B 144 THR GLN HIS GLY LYS VAL PRO LEU THR PHE PRO PRO GLY SEQRES 4 B 144 GLN GLY VAL PRO LEU ASN ALA ASN SER THR PRO ALA GLN SEQRES 5 B 144 ASN ALA GLY TYR TRP ARG ARG GLN ASP ARG LYS ILE ASN SEQRES 6 B 144 THR GLY ASN GLY ILE LYS GLN LEU ALA PRO ARG TRP TYR SEQRES 7 B 144 PHE TYR TYR THR GLY THR GLY PRO GLU ALA ALA LEU PRO SEQRES 8 B 144 PHE ARG ALA VAL LYS ASP GLY ILE VAL TRP VAL HIS GLU SEQRES 9 B 144 ASP GLY ALA THR ASP ALA PRO SER THR PHE GLY THR ARG SEQRES 10 B 144 ASN PRO ASN ASN ASP SER ALA ILE VAL THR GLN PHE ALA SEQRES 11 B 144 PRO GLY THR LYS LEU PRO LYS ASN PHE HIS ILE GLU GLY SEQRES 12 B 144 THR SEQRES 1 C 144 HIS HIS HIS HIS HIS HIS SER SER GLY LEU VAL PRO ARG SEQRES 2 C 144 GLY SER HIS MET ASN THR VAL SER TRP TYR THR GLY LEU SEQRES 3 C 144 THR GLN HIS GLY LYS VAL PRO LEU THR PHE PRO PRO GLY SEQRES 4 C 144 GLN GLY VAL PRO LEU ASN ALA ASN SER THR PRO ALA GLN SEQRES 5 C 144 ASN ALA GLY TYR TRP ARG ARG GLN ASP ARG LYS ILE ASN SEQRES 6 C 144 THR GLY ASN GLY ILE LYS GLN LEU ALA PRO ARG TRP TYR SEQRES 7 C 144 PHE TYR TYR THR GLY THR GLY PRO GLU ALA ALA LEU PRO SEQRES 8 C 144 PHE ARG ALA VAL LYS ASP GLY ILE VAL TRP VAL HIS GLU SEQRES 9 C 144 ASP GLY ALA THR ASP ALA PRO SER THR PHE GLY THR ARG SEQRES 10 C 144 ASN PRO ASN ASN ASP SER ALA ILE VAL THR GLN PHE ALA SEQRES 11 C 144 PRO GLY THR LYS LEU PRO LYS ASN PHE HIS ILE GLU GLY SEQRES 12 C 144 THR SEQRES 1 D 144 HIS HIS HIS HIS HIS HIS SER SER GLY LEU VAL PRO ARG SEQRES 2 D 144 GLY SER HIS MET ASN THR VAL SER TRP TYR THR GLY LEU SEQRES 3 D 144 THR GLN HIS GLY LYS VAL PRO LEU THR PHE PRO PRO GLY SEQRES 4 D 144 GLN GLY VAL PRO LEU ASN ALA ASN SER THR PRO ALA GLN SEQRES 5 D 144 ASN ALA GLY TYR TRP ARG ARG GLN ASP ARG LYS ILE ASN SEQRES 6 D 144 THR GLY ASN GLY ILE LYS GLN LEU ALA PRO ARG TRP TYR SEQRES 7 D 144 PHE TYR TYR THR GLY THR GLY PRO GLU ALA ALA LEU PRO SEQRES 8 D 144 PHE ARG ALA VAL LYS ASP GLY ILE VAL TRP VAL HIS GLU SEQRES 9 D 144 ASP GLY ALA THR ASP ALA PRO SER THR PHE GLY THR ARG SEQRES 10 D 144 ASN PRO ASN ASN ASP SER ALA ILE VAL THR GLN PHE ALA SEQRES 11 D 144 PRO GLY THR LYS LEU PRO LYS ASN PHE HIS ILE GLU GLY SEQRES 12 D 144 THR HET DJO A 201 21 HETNAM DJO (PHENYLMETHYL) (2S)-2-(HYDROXYMETHYL)-2,3- HETNAM 2 DJO DIHYDROINDOLE-1-CARBOXYLATE HETSYN DJO BENZYL 2-(HYDROXYMETHYL)-1-INDOLINECARBOXYLATE FORMUL 5 DJO C17 H17 N O3 HELIX 1 AA1 THR A 70 GLN A 73 5 4 HELIX 2 AA2 THR A 105 ALA A 109 5 5 HELIX 3 AA3 THR B 70 GLN B 73 5 4 HELIX 4 AA4 THR C 70 GLN C 73 5 4 HELIX 5 AA5 THR D 70 GLN D 73 5 4 HELIX 6 AA6 THR D 105 ALA D 109 5 5 SHEET 1 AA1 5 ILE A 120 HIS A 124 0 SHEET 2 AA1 5 ALA A 75 GLN A 81 -1 N GLY A 76 O VAL A 123 SHEET 3 AA1 5 ARG A 97 TYR A 102 -1 O TYR A 101 N TYR A 77 SHEET 4 AA1 5 LEU A 47 THR A 48 -1 N LEU A 47 O TRP A 98 SHEET 5 AA1 5 HIS A 161 ILE A 162 -1 O HIS A 161 N THR A 48 SHEET 1 AA2 5 ILE B 120 HIS B 124 0 SHEET 2 AA2 5 ALA B 75 ARG B 83 -1 N TRP B 78 O VAL B 121 SHEET 3 AA2 5 LEU B 94 TYR B 102 -1 O TYR B 99 N ARG B 79 SHEET 4 AA2 5 LEU B 47 GLN B 49 -1 N GLN B 49 O PRO B 96 SHEET 5 AA2 5 PHE B 160 ILE B 162 -1 O HIS B 161 N THR B 48 SHEET 1 AA3 3 TYR C 99 TYR C 102 0 SHEET 2 AA3 3 ALA C 75 ARG C 79 -1 N TYR C 77 O TYR C 101 SHEET 3 AA3 3 ILE C 120 HIS C 124 -1 O VAL C 123 N GLY C 76 SHEET 1 AA4 4 LEU D 47 THR D 48 0 SHEET 2 AA4 4 ARG D 97 TYR D 102 -1 O TRP D 98 N LEU D 47 SHEET 3 AA4 4 ALA D 75 ARG D 80 -1 N TYR D 77 O TYR D 101 SHEET 4 AA4 4 ILE D 120 HIS D 124 -1 O VAL D 123 N GLY D 76 SITE 1 AC1 7 VAL A 41 GLY A 106 PRO A 107 THR A 137 SITE 2 AC1 7 TRP C 43 PHE C 135 ASP C 143 CRYST1 35.440 109.897 91.526 90.00 101.10 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028217 0.000000 0.005537 0.00000 SCALE2 0.000000 0.009099 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011134 0.00000